These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9665041)

  • 21. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients.
    Villa E; Grottola A; Buttafoco P; Merighi A; Ferretti I; Trande P; Zoboli P; Camellini L; Callea F; De Palma M
    Clin Transplant; 1995 Jun; 9(3 Pt 1):160-4. PubMed ID: 7549054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation.
    Thomas RM; Brems JJ; Guzman-Hartman G; Yong S; Cavaliere P; Van Thiel DH
    Liver Transpl; 2003 Sep; 9(9):905-15. PubMed ID: 12942451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-Esteem Related to Quality of Life in Patients Over 60 Years Old Who Received an Orthotopic Liver Transplantation More Than 10 Years Ago.
    Jover-Aguilar M; Martínez-Alarcón L; Ramis G; Gago FA; Pons JA; Ríos A; Febrero B; García CC; Hiciano Guillermo AI; Ramírez P
    Transplant Proc; 2020 Mar; 52(2):562-565. PubMed ID: 32057494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
    Zimmermann T; Otto C; Hoppe-Lotichius M; Biesterfeld S; Lautem A; Knaak M; Zimmermann A; Barreiros AP; Heise M; Schattenberg JM; Sprinzl MF; Galle PR; Otto G; Schuchmann M
    Transplant Proc; 2009; 41(6):2549-56. PubMed ID: 19715972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.
    Utsumi M; Takaki A; Umeda Y; Koike K; Napier SC; Watanabe N; Sadamori H; Shinoura S; Yoshida R; Nobuoka D; Yasunaka T; Nakayama E; Yamamoto K; Fujiwara T; Yagi T
    Transpl Immunol; 2014 Jun; 31(1):33-41. PubMed ID: 24907425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation.
    Huang EJ; Wright TL; Lake JR; Combs C; Ferrell LD
    Hepatology; 1996 Mar; 23(3):396-404. PubMed ID: 8617417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation in hepatitis C. A Spanish multi-centre experience.
    Prieto M; Berenguer M; Rimola A; Loinaz C; Barrios C; Clemente G; Figueras J; Vargas V; Casafont F; Pons JA; Herrero JI
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):771-6. PubMed ID: 9831272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation.
    Trak-Smayra V; Contreras J; Dondero F; Durand F; Dubois S; Sommacale D; Marcellin P; Belghiti J; Degott C; Paradis V
    Transplantation; 2004 Jun; 77(11):1755-60. PubMed ID: 15201678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation.
    Baron PW; Sindram D; Higdon D; Howell DN; Gottfried MR; Tuttle-Newhall JE; Clavien PA
    Liver Transpl; 2000 Jul; 6(4):407-12. PubMed ID: 10915160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B and C in the liver transplant recipient: current understanding and treatment.
    Rosen HR
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S87-98. PubMed ID: 11689781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of early recurrence of hepatitis C on late biliary anastomotic stricture after liver transplantation.
    Fujikawa T; Fujita S; Mekeel KL; Reed AI; Foley DP; Kim RD; Howard RJ; Hemming AW
    Transplant Proc; 2006 Dec; 38(10):3661-2. PubMed ID: 17175360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
    Teixeira R; Pastacaldi S; Davies S; Dhillon AP; Emery VC; Rolles K; Davidson B; Patch D; Burroughs AK
    Transplantation; 2000 Nov; 70(10):1454-8. PubMed ID: 11118089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.